Literature DB >> 17657793

Second primary head and neck tumor risk in patients with cervical cancer--SEER data analysis.

Camille C Rose Ragin1, Emanuela Taioli.   

Abstract

BACKGROUND: Human papillomavirus (HPV) causes >99% of cervical carcinomas and is associated with approximately 25% of head and neck squamous cell carcinomas (HNSCCs). The role of HPV infection in HNSCC development after a first diagnosis of cervical cancer is unknown.
METHODS: Using the National Cancer Institute's Surveillance, Epidemiology, and End Results data, the authors compared the risk of second primary cancer (SPC) HNSCC in patients with cervical cancer with the general population and with females with other primary cancers.
RESULTS: The lifetime risk of SPC HNSCC for patients with cervical cancer was higher than in the general population (standardized incidence ratio [SIR]: 1.7). When compared with that in females with other cancers, the risk of anogenital and oropharyngeal SPC was in excess, but not of SPC in the oral cavity.
CONCLUSION: Patients with cervical cancer develop an excess SPC HNSCC in comparison with females with other cancers. A possible role of HPV is suggested. Copyright (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17657793     DOI: 10.1002/hed.20663

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  15 in total

1.  The association between histological subtype of a first primary endometrial cancer and second cancer risk.

Authors:  Jennifer Rhoades; Monica Hagan Vetter; James L Fisher; David E Cohn; Ritu Salani; Ashley S Felix
Journal:  Int J Gynecol Cancer       Date:  2018-12-21       Impact factor: 3.437

2.  Risk of Primary Neuroendocrine Pancreatic Tumor After a First Primary Cancer: A US Population-Based Study.

Authors:  Geetanjali R Kamath; Michelle K Kim; Emanuela Taioli
Journal:  Pancreas       Date:  2019-02       Impact factor: 3.327

3.  Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites.

Authors:  Kristina R Dahlstrom; Guojun Li; Guillermo Tortolero-Luna; Qingyi Wei; Erich M Sturgis
Journal:  Head Neck       Date:  2010-08-24       Impact factor: 3.147

4.  Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.

Authors:  Christian R Salazar; Richard V Smith; Madhur K Garg; Missak Haigentz; Bradley A Schiff; Nicole Kawachi; Nicole Anayannis; Thomas J Belbin; Michael B Prystowsky; Robert D Burk; Nicolas F Schlecht
Journal:  Head Neck Pathol       Date:  2013-09-04

5.  Racial disparities in risk of second primary cancers in endometrial cancer patients: Analysis of SEER Data.

Authors:  Ashley S Felix; Faina Linkov; G Larry Maxwell; Camille Ragin; Emanuela Taioli
Journal:  Int J Gynecol Cancer       Date:  2011-02-01       Impact factor: 3.437

6.  Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.

Authors:  Yuri Agrawal; Wayne M Koch; Weihong Xiao; William H Westra; Anna L Trivett; David E Symer; Maura L Gillison
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

7.  Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis.

Authors:  Malini Srinivasan; Emanuela Taioli; Camille C Ragin
Journal:  Carcinogenesis       Date:  2009-07-20       Impact factor: 4.944

Review 8.  Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications.

Authors:  P T Hennessey; W H Westra; J A Califano
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

9.  Bogarting that joint might decrease oral HPV among cannabis users.

Authors:  S R Zwenger
Journal:  Curr Oncol       Date:  2009-12       Impact factor: 3.677

10.  Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.

Authors:  Duncan C Gilbert; Katie Wakeham; Ruth E Langley; Claire L Vale
Journal:  Br J Cancer       Date:  2018-11-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.